Potential of stem/progenitor cells in treating stroke: the missing steps in translating cell therapy from laboratory to clinic.

Cesar V Borlongan1,2†, Michael Chopp3, Gary K Steinberg4, Tonya M Bliss4, Yi Li3, Mei Lu3, David C Hess1 & Douglas Kondziolka5 †Author for correspondence 1Medical College of Georgia and Augusta VA Medical Center, Department of Neurology, 1120 15th Street Augusta, GA 30904, USA 2Tel.: +1 706 721 2145; Fax: +1 706 721 7619; E-mail: cborlongan@ mail.mcg.edu 3Henry Ford Hospital, Department of Neurology, 2799 West Grand Blvd., Detroit, MI 48202, USA 4Stanford University School of Medicine, Department of Neurosurgery, R281, 300 Pasteur Drive, Stanford, CA, 94305, USA 5University of Pittsburgh, Department of Neurological Surgery, Suite B-400, UPMC, 200 Lothrop Street Pittsburgh, PA 15213, USA